Beyond dyspnoea as an endpoint in acute heart failure trials

Eur Heart J. 2011 Jun;32(12):1442-5. doi: 10.1093/eurheartj/ehr044. Epub 2011 Mar 8.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adenosine A1 Receptor Antagonists / administration & dosage*
  • Dyspnea / drug therapy*
  • Female
  • Heart Failure / drug therapy*
  • Humans
  • Male
  • Xanthines / administration & dosage*

Substances

  • Adenosine A1 Receptor Antagonists
  • Xanthines
  • rolofylline